Setup
Weeks
Log
Summary
Module 1 approach: Hold tirzepatide steady. Add low-dose retatrutide to introduce glucagon receptor activity while dual-agonist coverage continues.
Every RS is different. This is research — track what you observe, not what you “should” feel.
After the observation window, common next steps in research settings:
Rock Paper Peps Research Tool
Every RS is different. This is research — not medical advice.
Data stays on your device only.